{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:39:48Z","timestamp":1761709188362},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.numecd.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T04:20:33Z","timestamp":1459484433000},"page":"387-392","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes"],"prefix":"10.1016","volume":"26","author":[{"given":"P.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Winhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Krssak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Smajis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Harreiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kosi-Trebotic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"F\u00fcrnsinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-H.","family":"Anderwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Baumgartner-Parzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Trattnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Luger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2016.03.012_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/clc.4960180604","article-title":"Cardiac consequences of diabetes mellitus","volume":"18","author":"Shehadeh","year":"1995","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.numecd.2016.03.012_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/HCO.0b013e3282fcc2fa","article-title":"Nonischemic heart failure in diabetes mellitus","volume":"23","author":"Guha","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.numecd.2016.03.012_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0008-6363(97)00047-3","article-title":"Regulation of energy substrate metabolism in the diabetic heart","volume":"34","author":"Stanley","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.numecd.2016.03.012_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbalip.2009.09.023","article-title":"Lipotoxicity in the heart","volume":"1801","author":"Wende","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.numecd.2016.03.012_bib5","doi-asserted-by":"crossref","first-page":"e000433","DOI":"10.1161\/JAHA.113.000433","article-title":"Taking diabetes to heart\u2013deregulation of myocardial lipid metabolism in diabetic cardiomyopathy","volume":"2","author":"Bayeva","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2016.03.012_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11892-008-0042-x","article-title":"The complexity of diabetic cardiomyopathy: lessons from patients and animal models","volume":"8","author":"Harmancey","year":"2008","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.numecd.2016.03.012_bib7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","article-title":"Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study","volume":"116","author":"McGavock","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2016.03.012_bib8","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00125-011-2146-0","article-title":"Insulin resistance is not associated with myocardial steatosis in women","volume":"54","author":"Kr\u0161\u0161\u00e1k","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2016.03.012_bib9","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","article-title":"Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus","volume":"52","author":"Rijzewijk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2016.03.012_bib10","doi-asserted-by":"crossref","first-page":"E714","DOI":"10.1152\/ajpendo.90413.2008","article-title":"Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus","volume":"295","author":"Hammer","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.numecd.2016.03.012_bib11","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/db11-1275","article-title":"Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects","volume":"61","author":"Winhofer","year":"2012","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.numecd.2016.03.012_bib12","doi-asserted-by":"crossref","first-page":"E631","DOI":"10.1152\/ajpendo.00371.2014","article-title":"Free fatty acid availability is closely related to myocardial lipid storage and cardiac function in hypoglycemia counter-regulation","volume":"308","author":"Winhofer","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.numecd.2016.03.012_bib13","doi-asserted-by":"crossref","first-page":"E1721","DOI":"10.1210\/jc.2014-1541","article-title":"Cardiometabolic phenotyping of patients with familial hypocalcuric hypercalcemia","volume":"99","author":"Wolf","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2016.03.012_bib14","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2014-2242","article-title":"No evidence of ectopic lipid accumulation in the pathophysiology of the acromegalic cardiomyopathy","volume":"99","author":"Winhofer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2016.03.012_bib15","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","article-title":"Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women","volume":"109","author":"Peterson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2016.03.012_bib16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jacc.2009.04.074","article-title":"Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging","volume":"54","author":"Rijzewijk","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2016.03.012_bib17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10354-014-0292-y","article-title":"Intracellular lipid accumulation and shift during diabetes progression","volume":"164","author":"Wolf","year":"2014","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.numecd.2016.03.012_bib18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.hfc.2012.06.007","article-title":"Diabetic cardiomyopathy: bench to bedside","volume":"8","author":"Schilling","year":"2012","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.numecd.2016.03.012_bib19","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/01.CIR.0000012466.50373.E8","article-title":"Adaptation and maladaptation of the heart in diabetes: part I: general concepts","volume":"105","author":"Taegtmeyer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2016.03.012_bib20","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1161\/CIRCULATIONAHA.106.645184","article-title":"Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure","volume":"114","author":"Tuunanen","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2016.03.012_bib21","doi-asserted-by":"crossref","first-page":"H1220","DOI":"10.1152\/ajpheart.00475.2010","article-title":"Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function","volume":"299","author":"Halbirk","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.numecd.2016.03.012_bib22","doi-asserted-by":"crossref","first-page":"E941","DOI":"10.1152\/ajpendo.1994.267.6.E941","article-title":"Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans","volume":"267","author":"Nuutila","year":"1994","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.numecd.2016.03.012_bib23","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1210\/jc.2012-1219","article-title":"Effects of acute and one-week fatty acid lowering on cardiac function and insulin sensitivity in relation with myocardial and muscle fat and adiponectin levels","volume":"97","author":"Lehto","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2016.03.012_bib24","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/eurheartj\/ehn207","article-title":"The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function","volume":"29","author":"van der Meer","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2016.03.012_bib25","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1210\/jc.2006-0584","article-title":"Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels","volume":"91","author":"Kankaanpaa","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2016.03.012_bib26","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1210\/jcem.86.12.8075","article-title":"Skeletal muscle lipid content and insulin resistance evidence for evidence for a paradox in endurance-trained athletes","volume":"86","author":"Goodpaster","year":"2001","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315301332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315301332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T01:09:17Z","timestamp":1567732157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475315301332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0939475315301332"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2016.03.012","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}